Nath Bio-Genes

{
  "main_header": {
    "sid": 628630,
    "name": "Nath Bio-Genes",
    "stock_name": "Nath Bio-Genes",
    "full_name": "Nath Bio-Genes (India) Ltd",
    "name_url": "stocks-analysis/nath-bio-genes",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "149.91",
    "chg": 2.57,
    "chgp": "1.74%",
    "dir": 1,
    "prev_price": "147.34",
    "mcapval": "284.89 Cr",
    "mcap": "Micro Cap",
    "scripcode": 537291,
    "symbol": "NATHBIOGEN",
    "ind_name": "Other Agricultural Products",
    "ind_code": 107,
    "sector_id": 53,
    "indexname": "India SENSEX",
    "isin": "INE448G01010",
    "curr_date": "Sep 21, 11:06 AM",
    "curr_time": "11:25 AM",
    "last_traded_at": "Sep 21, 11:06 AM IST",
    "bse_nse_vol": "1.02 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 21, 2026",
    "traded_date_str": "2026 09 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nath-bio-genes-628630-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Nath Bio-Genes Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-4199233",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NathBioGenesInd_mojoScore_4199233.png",
        "date": "2026-09-21 08:11:54",
        "description": "Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 Sep 2026. This shift reflects deteriorating technical indicators, stagnant financial trends, weak quality metrics, and valuation concerns, signalling heightened caution for investors amid persistent underperformance against benchmarks."
      },
      {
        "title": "Nath Bio-Genes Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-forms-death-cross-signalling-potential-bearish-trend-4197719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NathBioGenesInd_dealthcross_4197719.png",
        "date": "2026-09-18 18:00:22",
        "description": "Nath Bio-Genes (India) Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and long-term weakness in the stock’s price action."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-4190468",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NathBioGenesInd_mojoScore_4190468.png",
        "date": "2026-09-11 10:10:22",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-4173395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NathBioGenesInd_mojoScore_4173395.png",
        "date": "2026-08-28 10:10:23",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 22 June 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 28 August 2026, providing investors with the latest perspective on the company’s performance and prospects."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-4157867",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NathBioGenesInd_mojoScore_4157867.png",
        "date": "2026-08-17 10:10:20",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 17 August 2026, providing investors with the latest comprehensive analysis."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-4139572",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NathBioGenesInd_mojoScore_4139572.png",
        "date": "2026-08-06 10:11:57",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are Nath Bio-Genes (India) Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-nath-bio-genes-india-ltd-latest-results-good-or-bad-4129054",
        "imagepath": "",
        "date": "2026-07-30 19:20:25",
        "description": "Nath Bio-Genes (India) Ltd reported its financial results for Q1 FY27, showcasing a notable performance in terms of net sales and net profit. The company achieved net sales of ₹328.40 crores, reflecting a year-on-year growth of 15.76% compared to ₹283.70 crores in Q1 FY26. This growth is indicative of the seasonal strength typically seen in the agricultural sector, particularly in the first quarter, which aligns with peak harvest and trading periods.\n\nThe net profit for the quarter stood at ₹32.26 crores, marking a year-on-year increase of 14.07%, a significant recovery from a marginal loss in the previous quarter (Q4 FY26). However, it's important to note that the profit margins exhibited some compression, with the PAT margin slightly decreasing to 9.82% from 9.97% in Q1 FY26, suggesting that while sales growth is present, it hasn't fully translated into proportional profit growth.\n\nThe operating profit (P..."
      },
      {
        "title": "Nath Bio-Genes Q1 FY27: Strong Profit Surge Masks Underlying Quality Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/nath-bio-genes-q1-fy27-strong-profit-surge-masks-underlying-quality-concerns-4127576",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NathBioGenesInd_quaterlyResult_4127576.png",
        "date": "2026-07-29 21:31:29",
        "description": "Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹319.00 crores, reported a consolidated net profit of ₹32.26 crores for Q1 FY27, representing a remarkable year-on-year growth of 14.07% from ₹28.28 crores in Q1 FY26. However, the stock has declined 1.47% following the results announcement, closing at ₹161.15, as investors grapple with the company's persistent quality challenges and weak long-term fundamental strength."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-4121039",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NathBioGenesInd_mojoScore_4121039.png",
        "date": "2026-07-26 10:10:40",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 183,
    "sid": "628630",
    "stock_news_url": "https://www.marketsmojo.com/news/nath-bio-genes-india-628630"
  },
  "announcements": [
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding Related Party Transaction for the half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Other General Purpose",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding Investor Presentation on unaudited financial results for the period ended 30th sep 2019",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Investor Presentation",
      "datetime": "04-Nov-2019"
    },
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding 'Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.'.",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Updates",
      "datetime": "30-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nath Bio-Genes (India) Ltd has declared <strong>20%</strong> dividend, ex-date: 11 Sep 26",
          "dt": "2026-09-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nath Bio-Genes Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-09-21 08:11:54

Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 Sep 2026. This shift reflects deteriorating technical indicators, stagnant financial trends, weak quality metrics, and valuation concerns, signalling heightened caution for investors amid persistent underperformance against benchmarks.

Read full news article

Nath Bio-Genes Forms Death Cross, Signalling Potential Bearish Trend

2026-09-18 18:00:22

Nath Bio-Genes (India) Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and long-term weakness in the stock’s price action.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Sell

2026-09-11 10:10:22

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Sell

2026-08-28 10:10:23

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 22 June 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 28 August 2026, providing investors with the latest perspective on the company’s performance and prospects.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Sell

2026-08-17 10:10:20

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 17 August 2026, providing investors with the latest comprehensive analysis.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Sell

2026-08-06 10:11:57

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Are Nath Bio-Genes (India) Ltd latest results good or bad?

2026-07-30 19:20:25

Nath Bio-Genes (India) Ltd reported its financial results for Q1 FY27, showcasing a notable performance in terms of net sales and net profit. The company achieved net sales of ₹328.40 crores, reflecting a year-on-year growth of 15.76% compared to ₹283.70 crores in Q1 FY26. This growth is indicative of the seasonal strength typically seen in the agricultural sector, particularly in the first quarter, which aligns with peak harvest and trading periods. The net profit for the quarter stood at ₹32.26 crores, marking a year-on-year increase of 14.07%, a significant recovery from a marginal loss in the previous quarter (Q4 FY26). However, it's important to note that the profit margins exhibited some compression, with the PAT margin slightly decreasing to 9.82% from 9.97% in Q1 FY26, suggesting that while sales growth is present, it hasn't fully translated into proportional profit growth. The operating profit (P...

Read full news article

Nath Bio-Genes Q1 FY27: Strong Profit Surge Masks Underlying Quality Concerns

2026-07-29 21:31:29

Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹319.00 crores, reported a consolidated net profit of ₹32.26 crores for Q1 FY27, representing a remarkable year-on-year growth of 14.07% from ₹28.28 crores in Q1 FY26. However, the stock has declined 1.47% following the results announcement, closing at ₹161.15, as investors grapple with the company's persistent quality challenges and weak long-term fundamental strength.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Sell

2026-07-26 10:10:40

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News